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ttp://dx.doi.org/10.1016/j.jmoldx.2012.06.007DNA methylation is critical for gene silencing and is associated with the incidence of many diseases,
including cancer. Underlying molecular mechanisms of human diseases and tissue-speciﬁc gene
expression have been elucidated based on DNA methylation studies. This review highlights the
advantages and drawbacks of various methylation screening techniques: blotting, genomic sequencing,
bisulﬁte sequencing, methylation-speciﬁc PCR, methylated DNA immunoprecipitation, microarray
analysis, matrix-assisted laser desorption ionization time-of-ﬂight mass spectroscopy, nanowire tran-
sistor detection procedure, quantum dot-based nanoassay, single-molecule real-time detection, ﬂuo-
rimetric assay, electrochemical detection, and atomic force spectroscopy. The review provides insight
for selecting a method or a combination of methods for DNA methylation analysis. Convergence of
conventional and contemporary nanotechniques to enumerate methylation at speciﬁc CpG sites of
oncogene would ﬁll the gap in diagnosis of cancer. (J Mol Diagn 2013, 15: 17e26; http://dx.doi.org/
10.1016/j.jmoldx.2012.06.007)Supported by the Department of Biotechnology (project BT/PR10018/
NNT/28/95/2007), the Department of Science & Technology (project SR/
NM/P G-05/2008), and a Senior Research Fellowship from the Council of
Science and Industrial Research [09/960(002)/2K9-EMR-I].
R.S., N.B.B., and L.A. contributed equally to this work.DNA methylation, an epigenetic alteration, plays a key role in
transcriptional control; it occurs when a methyl group is added
to the ﬁfth carbon of cytosine or at the sixth carbon of adenine
and is catalyzed by speciﬁc DNA methyl transferases.1 Aber-
rant cytosine methylation is associated with silencing of tumor
suppressor genes2 and plays a decisive role in the development
of many cancers, such as colorectal,3e5 lung,6,7 liver,8 and
breast9 cancers. Alterations in the methylation status of DNA
are promising candidates for a highly speciﬁc and sensitive
indicator of cancer diagnosis and prognosis.10e12 Apart from
carcinogenesis, DNA methylation is crucial for a variety of
processes, such as genomic imprinting, X-chromosome inac-
tivation, and suppression of repetitive elements.1,13stigative Pathology
.Genome-wide hypomethylation results in chromosomal
instability14 and increased mutation rates,15 whereas pro-
moter hypermethylation suppresses gene transcription by
either preventing transcription factors from binding to the
gene or altering chromatin structure.1
DNA hypermethylation contributes to oncogenesis by
point mutation and inactivation of tumor suppressor gene,
Figure 1 An overview of methylation detection techniques.
Shanmuganathan et alwhereas hypomethylation may lead to chromosomal insta-
bility and activation of proto-oncogene.1 Tumor growth is
characterized by genome-wide hypomethylation, accompa-
nied by hypermethylation of tumor suppressor gene
promoters caused by increased expression of DNA methyl-
transferases.2 Changes in DNAmethylation in cancer include
both global hypomethylation and gene-speciﬁc hyper-
methylation. Whether global hypomethylation and gene-
speciﬁc hypermethylation are mutually exclusive or not
remains ambiguous.16,17 CpG methylation analysis is useful
in detecting the progression of tumor, classiﬁcation of
disease, diagnosis, and prognosis of various types of human
cancer. Methylation analysis is also useful for risk assess-
ment of patients with prolonged viral and bacterial infections.
In breast cancer diagnosis, CpG abnormality of genes, such
as ESR1,18,19 CDKN2A,20 PAR,21 MDGI,22 CALCA,23
CDH1,24 LATS1,25 and LATS2,25 is well illustrated.
Although it has been proved that most of the genes respon-
sible for breast cancer are linked with abnormal CpG meth-
ylation, the clinical relevance of methylation analysis for
diagnosis and prognosis of breast cancer warrants additional
studies.26 CpG methylation is useful in monitoring the
progression of cervical cancer because promoter-speciﬁc
methylation aberration was relatively high in DAPK1,
CADM1, and CDKN2A (p16) genes in invasive cervical
cancers, compared with high-grade squamous intraepithelial
lesions.27 The progression of cervical cancer from a squa-
mous intraepithelial lesion requires additional genetic
modiﬁcation and, hence, methylation proﬁling at the initial
stage may be a powerful tool to study the disease develop-
ment and risk assessment.26
The role of DNA methylation in cancer has been widely
accepted as a consequence of introduction of CpG island
methylator phenotype in colorectal cancer, followed by
focus on clinical and pathological features of CpG island
methylator phenotype, and its characterization in tumors.28
DNA methylation inhibitors (namely, azacitidine and deci-
tabine) are used clinically in low doses to treat myelodys-
plastic syndrome, serving as a proof for epigenetic therapy.
Although methylation inhibition is a targeted therapy,
downstream effects are non-speciﬁc, causing cytotoxicity
and making clinical predictions difﬁcult.29 Molecular path-
ological epidemiology deals with the interrelationship
between exogenous and endogenous factors, tumor
biomarkers, and progression. Despite the challenges, an
integration of genome-wide association studies with the
molecular pathological epidemiology represents a promising
area for personalized prevention and therapy of cancer.30
This review focuses on the fundamental distinctions
and attributes of the following methylation screening tech-
niques: blotting, genomic sequencing, bisulﬁte sequencing,
methylation-speciﬁc PCR, methylated DNA immunopre-
cipitation, microarray analysis, matrix-assisted laser desor-
ption time-of-ﬂight mass spectroscopy (MALDI-TOF MS),
a nanowire transistor detection procedure, a quantum-
dot (QD) nanoassay, single-molecule real-time (SMRT)18detection, a ﬂuorimetric assay, electrochemical detection,
and atomic force spectroscopy. Figure 1 illustrates the
representative conventional and nanotechniques for DNA
methylation analysis.
Conventional Techniques
Blotting
Antibodies raised against 5-methylcytosine are applied to
a DNA sample immobilized on a nitrocellulose membrane to
identify 5-methylcytosine in DNA. The 5-methylcytosine
sequentially reacts with primary antibody and radiolabeled
secondary antibody and is then visualized using autoradiog-
raphy. Although this method can precisely detect every
methylated cytosine in DNA, there are two potential
complications: ﬁrst, the occurrence of partial renaturation
of double-stranded DNA blotted on the nitrocellulose
membrane; and second, the diminished efﬁciency of detection
due to steric hindrance in concentrated DNA samples.31,32
The latter effect is the result of hindrance caused by the two
Fab (antigen-binding fragment) arms of the antibody. The
partial renaturation of the DNA can be eliminated by using
irreversible denaturation reagents, and steric hindrance can be
avoided by using an Fab instead of the whole antibody.
Bisulﬁte Sequencing
Conventional sequencing methods use Maxam and Gilbert
chemical cleavage reactions, along with ampliﬁcation proce-
dures, to establish the methylation status of the promoters in
tumor-responsive genes.33e35 The advantage of conventional
sequencing methods is their ability to detect protein-binding
sites on genomic DNA in vivo.34,36 Nevertheless, majorjmd.amjpathol.org - The Journal of Molecular Diagnostics
Figure 2 Analysis of methylation by base-speciﬁc cleavage and MALDI-
TOF MS. Reproduced from Ehrich et al,81 with permission of the
National Academy of Sciences, Washington, DC (copyright 2005).
DNA Methylation Proﬁlingissues exist in the identiﬁcation of 5-methylcytosine residues,
because a methylated cytosine is identiﬁed by the absence of
bands in all of the lanes of a sequencing gel.37 Consequently,
errors occur because of indeterminate bands or a background
cleavage ladder. Furthermore, sequencing protocols cannot be
used for small or mixed DNA samples.37
Genomic sequencing protocols have been augmented to
sodium bisulﬁteemediated sequencing to circumvent the
existing drawbacks in identifying methylated cytosine.
Bisulﬁte sequencing is widely used for mapping of promoter
hypermethylation and epigenotyping. In this method, cyto-
sine is converted to uracil, leaving methylated cytosine
intact.38e41 Subsequent PCR ampliﬁcation of the modiﬁed
DNA, using methylation-speciﬁc and non-speciﬁc primer
pairs, replaces all uracil nucleotides with thymine, producing
methylation-speciﬁc single-nucleotide alterations that can be
identiﬁed with conventional sequencing and alignment
against the reference sequence.37,40
Recent array-based strategies also exploit bisulﬁte-
modiﬁed DNA to screen for deﬁned regions using bimodal
hybridization of unconverted or converted regions. A bisulﬁte
conversion protocol compatible with ultra-high-throughput
sequencing could be used to assess the methylomes at single-
CpG resolution, even in large genomes.42e44 However,
a relatively uneven CpG distribution makes this technique
unsuitable for comparative studies involving larger genomes.
Comparative DNA methylation proﬁling is easily achieved
with reduced representation bisulﬁte sequencing.45e48
Reduced representation bisulﬁte sequencing is akin to
bisulﬁte sequencing, but it also enriches its libraries through
restriction digestion of genomic DNA with endonucleases
speciﬁc for CpG-containing motifs.48
Methylated DNA Immunoprecipitation
Methylated DNA immunoprecipitation has provided the
preliminary methylome proﬁles of the whole genome of
Arabidopsis49 and for mammalian promoters.50 Genomic
DNA is fragmented to an average size of 400 to 500 bp,
bound to MBD-Fc sepharose beads and then fractionated
using NaCl. Gene fragments are quantiﬁed using real-time
PCR on each fraction for single-gene analysis. Instead of
single-gene analysis, individual fractions may also be used
for dual-color microarray analysis.51,52 Although identiﬁ-
cation of immunoprecipitable 5-methyl-CpGecontaining
fragments is possible, the accuracy of detecting individual
CpG sites using the methylated DNA immunoprecipitation-
seq method is low; hence, this method needs further
improvement to be used for diagnosis.
Restriction EnzymeeBased Methods
Methylation status can be assessed onDNA fragments cleaved
by methylation-sensitive restriction enzymes using Southern
blot hybridization techniques or PCR ampliﬁcation.53,54The Journal of Molecular Diagnostics - jmd.amjpathol.orgLonger fragments that result from the inability of the
enzymes to cleave methylated sequences indicate a methyl-
ated CpG dinucleotide.55 Although restriction enzyme-
based methods are simple, rapid, and extremely sensitive,
they are limited to speciﬁc restriction sites and require
a substantial amount of high-quality DNA.53 The technique
is, therefore, appropriate for genome-wide methylation
analysis and marker discovery techniques but is less useful
for investigating the methylation status of speciﬁc CpG
sites.53
MSP Methods
A methylation-speciﬁc PCR is used to evaluate and quan-
tify methylation status identiﬁed based on bisulﬁte reac-
tivity. Methylation-speciﬁc PCR (MSP) uses two distinct
methylation-speciﬁc primer sets for the sequence of interest.
An unmethylated primer will only amplify sodium bisul-
ﬁteeconverted unmethylated DNA, whereas a methylated
primer is speciﬁc for sodium bisulﬁteetreated methylated
DNA.56 It provides a sensitive, quick, and cost-effective test
for the methylation status of CpG dinucleotides in a CpG
island, making the technique applicable for high-throughput
analysis of clinical samples.53,57
Although this approach yields detailed data on the
methylation status of all CpG sites, it is laborious and time-
consuming.53,54 MSP data represent only a small percentage
of the analyzed cells in a population, unless performed using
semiquantitative PCR.58 Furthermore, the extent of meth-
ylation heterogeneity occurring in loss of expression during
tumorigenesis is ill deﬁned, and the exact timing of meth-
ylation changes is not well studied in speciﬁc cell types
during carcinogenesis and embryonic development.5819
Figure 4 Schematic depiction of methylation detection via methylation-
speciﬁc FRET. A: Representative methylated and unmethylated genomic DNA
sequences. B: Sodium bisulﬁte conversion of unmethylated cytosines into
uracil whilemethylated cytosines remain unconverted. C: PCR ampliﬁcation is
methylation dependent as a result of primer sequencing and the variation
between bisulﬁte-treated DNA. Cy5-deoxy-CTP (red circles) incorporates
throughout the target sequence of each amplicon. Forward primers contain
a biotin label (blue triangles) for post-PCR conjugation to QDs. The unme-
thylated DNA template does not become ampliﬁed with methylation-speciﬁc
primers.D: The target is conjugated to QD (FRET donor) by biotin-streptavidin
afﬁnity on excitation at 488 nm; QD emission is recorded at 605 nm and Cy5
(FRET acceptor) at 670 nm. Reproduced fromBailey et al,89 with permission of
Elsevier, Philadelphia, PA (copyright 2010).
Shanmuganathan et alQuantitative MSP
Quantitative MSP protocols adopt the advantages of real-
time PCR using ﬂuorescent-labeled MSP primers and
TaqMan probes59,60 to precisely quantify the number of
methylated alleles. Quantiﬁcation of methylation typically
reﬂects the actual changes in methylation density of tumor
DNA. Quantitative MSP is rapid because it bypasses the
additional PCR steps, gel electrophoresis, or hybridization. A
drawback of this method is the occurrence of false-positive
results caused by the ampliﬁcation of unconverted DNA.61
Multiplex Nested MSP
To increase the sensitivity ofMSP, a nested two-stageMSPwas
introduced.62 The ﬁrst stage uses primers that amplify sodium
bisulﬁteemodiﬁed DNA, but methylated and unmethylated
alleles are barely discriminated. The amplicon is diluted and
subjected to a second PCR using U- and M-speciﬁc MSP
primers. Unlike conventionalMSP, methylation analysis using
nested MSP is possible even when testing clinical samples of
poor quality or limited quantity. This two-stage variant ofMSP
yields complete methylation proﬁles for gastrointestinal
stromal tumors57 and hepatocellular carcinomas.63 However,
false-positive results owing to a lack of the single-strand
conformation, renaturation, and incomplete sodium bisulﬁte
conversion caused by the protection of a methylated cytosine
by the neighboring, unmethylated cytosine remain as limita-
tions.53,64,65QuantitativemultiplexnestedMSPwasdeveloped
to generate a more sensitive quantitative MSP platform.66
Quantitative multiplex nested MSP is similar to multiplex
nested MSP, except for the use of probes in addition to the
U- and M-speciﬁc primers in the second round of PCR.
In Situ MSP
MSP can be coupled with in situ hybridization to enhance
detection67 to the cellular level. This technique tests tissueFigure 3 An overview of the nanowire-based detection technique.
Reproduced from Maki et al,85 with permission of Elsevier, Phila-
delphia, PA (copyright 2008).
20samples using two different sets of primers for in situMSP.
Methylation is determined based on the color obtained.
Initially, three sequential tissue sections are placed on
a slide, treated with sodium bisulﬁte, and analyzed using in
situ MSP.68 One slide is analyzed with U-primers, one
slide is analyzed with M-primers, and the ﬁnal slide is
analyzed with no primers as a control. Digoxin-labeled
probes designed speciﬁcally for the U and M products
generated for solution-phase MSP are added, followed by
in situ hybridization analysis and nuclear fast red staining.
This technique can be used for the following applications:
investigating the role of CpG island methylation during
embryogenesis, analyzing developmental timing, and
aberrant imprinting in speciﬁc cell types; studying
mammalian X-chromosome inactivation; evaluating tumor
progression in heterogeneous clinical samples; and
understanding the cellular consequences of methylation for
gene expression.53,67Microarray Analysis
Microarrays, highly speciﬁc and capable of high-throughput
analysis of multiple samples or multiple target regions, are
especially useful for screening many clinical samples.69
Genomic DNA is treated with sodium bisulﬁte, and thejmd.amjpathol.org - The Journal of Molecular Diagnostics
Figure 5 Principle and corresponding example of detecting DNA methylation during SMRT sequencing. A: Schematics of polymerase synthesis of DNA
strands containing a methylated (top) or an unmethylated (bottom) adenosine. B: Typical SMRT sequencing ﬂuorescence traces. Reproduced from Flusberg
et al,91 with permission of Nature Publishing Group, London, UK (copyright 2010).
Figure 6 Background-subtracted square-wave voltammograms (SWVs).
A total of 3 mM of CpG oligonucleotides (1 to 4) at electron-cyclotron-
resonance nanocarbon ﬁlm electrode in 50 mM, pH 5.0, acetate buffer
containing 0.3 mol/L NaNO3 is used. Acetate buffer (pH 5.0) is the most
appropriate for obtaining well-deﬁned peaks with high sensitivity.12 The
amplitude is 25 mV; 6E, 5 mV; and frequency, 10 Hz. Reproduced from
Kato et al,95 with permission of American Chemical Society Publica-
tions, Washington, DC (copyright 2008).
DNA Methylation Proﬁlingtargeted region is PCR ampliﬁed with amino-modiﬁed
primers to distinguish between the methylated and unme-
thylated states of CpG sites. The original methylated CpG
dinucleotides are converted to unmethylated CpG dinucle-
otides, whereas the original unmethylated CpG dinucleo-
tides are converted to TpG dinucleotides. The methylation
density of targeted fragments is detected with a ﬂuorescence
marker system in which Cy3-labeled speciﬁc oligonucleo-
tide probes are designed against methylated and unmethy-
lated DNA targets and hybridize to the ampliﬁed product,
which is labeled with Cy5 ﬂuorescence dye.70
The ratio of Cy5 and Cy3 signals (differential concen-
tration of methyl-M/methyl-U) is normalized to establish
a standard curve and to evaluate the methylation density of
the ampliﬁed sequences.71,72 Background hybridization
signals can be reduced by adjusting the stringency of
hybridization and slide-washing conditions.71 The major
limitation of this technique is that it cannot determine the
methylation status of individual CpG sites.73e76
The differential methylation hybridization approach alle-
viates the limitations of conventional microarray techniques
using the following three unique features: i) a high-density,
DNA arrayebased screening strategy that has been used in
differential screenings of thousands of cDNA sequences up-
or down-regulated in complex biological systems; ii) a more
precise measurement of the frequencies and extent of
methylation of the tested CpG island loci in the tumor
genome; and iii) the genomic fragments being derived from
a library speciﬁcally constructed to contain highly enriched
CpG island sequences. Differential methylation hybridiza-
tion may pave the path for identiﬁcation of novel tumor-
suppressor genes down-regulated via methylation in
cancer.77,78The Journal of Molecular Diagnostics - jmd.amjpathol.orgNovel Techniques
Although conventional methods are sensitive, they often
generate false positives. New detection techniques, such as
MALDI-TOF MS, nanowire transistor, QD assay, SMRT
detection, ﬂuorimetric assay, electrochemical detection, and
force spectroscopy, have greater accuracy.
MALDI-TOF Mass Array Analysis
MALDI-TOF MS is a quantitative, ﬂexible, nonradioactive
technique with a wide range of applications. Its main
advantages are direct detection of DNA methylation and the
possibility of analyzing the methylation of several21
Figure 7 Schematic representation of force measurements using AFM.
A: Single-stranded DNA (ssDNA) is conjugated to a glass surface through an
amine group at its 30 end, and the antibody is conjugated to the cantilever
tip via ﬂexible polyethylene glycol cross-linkers. The two Fab arms and the
Fc arm of the antibody are indicated. B: A typical force-distance curve
measured with an AFM showing a single unbinding event. C: The distribution
of the unbinding force between ssDNA and antie5-methylcytidine antibody
obtained at a loading rate of 2 nN/second showed a maximum at approxi-
mately 57 pN for ssDNA containing ﬁve 5-methylcytidines (grey line). By
injecting DNA molecules containing 5-methylcytidines into solution, the
binding probability (percentage of curves containing an unbinding event)
decreased from 55% (n Z 660) to 13% (n Z 1201), demonstrating the
speciﬁcity of the interaction between 5-methylcytidine and antibody. D:
Unbinding forces between antibody and DNA containing one (square) or ﬁve
(circles) 5-methylcytidines at different force loading rates. The unbinding
forces (maxima of distributions, such as the one shown in C), followed by
a logarithmic dependence on the loading rate (D). Reproduced in black and
white from Zhu et al,99 with permission of Nature Publishing Group, London,
UK and Peter Hinterdorfer (supplementary information) (copyright 2010).
Shanmuganathan et alcompeting substrates.79 Bisulﬁte-treated genomic DNA is
tagged during PCR with the T7-promoter sequence.80 After
shrimp alkaline phosphatase treatment, in vitro transcription
occurs using T7R, DNA polymerase, and a speciﬁc nucle-
otide, and the product is cleaved with RNase A.80 This
transcription results in a speciﬁc fragmentation pattern,
which is analyzed using MALDI-TOF MS (Figure 2). Mass
signals of the cleavage product differ by 32 Da when both
CpG sites are methylated compared with when none of the
site is methylated.81 The primary drawback of this technique
is the variability in mass/charge ratios of protein-ion signals
along the x axis of spectra, which impedes the development
of robust data analysis algorithms.81
Nanowire Transistor
Field effect transistorebased charge detectors have shown
promising results in the detection of DNA molecules and
have the attractive features of being label free and highly
sensitive.82e85 In a nano ﬁeld effect transistor technique,
a D-biotinelabeled, sequence-speciﬁc probe is used to
capture the target DNA (Figure 3). Methylated DNA mole-
cules are captured by monoclonal antie5-methylcytosine22antibodies, which are immobilized on the sensing surface.
Changes in the electronic charge of the DNA backbone,
caused by captured molecules, alter the electrical properties
of the nano ﬁeld effect transistor and generate a detectable
electronic signal.85 Surface modiﬁcation of silicon to pattern
the biomolecules on oxide dots of nanorange using atomic
force microscopy (AFM) anodic oxidation developed
a sensing element.86 The development of sensing element
processing, characterization, interface problems, the avail-
ability of high-quality nanomaterials, the tailoring of nano-
materials, the mechanisms governing the behavior of these
nanoscale composites on the surface of electrodes, enhance-
ment of the signal/noise ratio, and ampliﬁcation of signals are
all great challenges for accurate methylation detection using
a nanowire transistor. In addition, the mechanisms underlying
the interactions between biomolecules and nanomaterials are
not yet well understood.87QD-Based Nanoassay
Methylation-speciﬁc QD ﬂuorescence resonance energy
transfer (FRET) detects methylation status in a sensitive and
quantiﬁable manner.88 Template DNA (Figure 4A) is ﬁrst
treated with sodium bisulﬁte (Figure 4B),89 and the converted
template is ampliﬁed using biotinylated methylation-speciﬁc
primers (Figure 4C).89 Quantum dots, functionalized with
streptavidin, serve as both a scaffold to capture amplicons
and a donor for transferring energy to the Cy5 acceptor that is
incorporated into the amplicons during PCR (Figure 4D).89
The low background noise and high signal from QD-FRET
allow for convenient and reliable detection of methylation
without compromising speciﬁcity.90 This method transforms
the qualitative technique of highly speciﬁc MSP,56 the most
commonly used methylation detection system, into a more
sensitive assay that is appropriate for high-throughput
screening. Methylation-speciﬁc QD-FRET is effective for
directly detecting methylation in both DNA-rich samples,
such as tumors and cell lines, and DNA-scarce samples, such
as serum and sputum.89 This technique is also effective for
detecting promoter methylation status.88SMRT Monitoring Using Nanostructured Materials
The SMRT technique can detect N6-methyladenine,
5-methylcytosine, and 5-hydroxymethylcytosine in DNA
methylation, without bisulﬁte conversion. Figure 5 shows
the principle and an illustration of detecting DNA methyl-
ation during SMRT sequencing.91 Fluorescently labeled
nucleotides are incorporated into complementary nucleic
acid strands by DNA polymerase in this technique. Unique
kinetic signatures for each of the bases enable their
discrimination in the same DNA sample. Measurement of
polymerase kinetics is an important part of SMRT
sequencing, and it does not intervene much with determi-
nation of the primary DNA sequence.91jmd.amjpathol.org - The Journal of Molecular Diagnostics
DNA Methylation ProﬁlingResearchers have demonstrated methylation, and DNA
damage, using polymerase without any additional sample
preparation steps. The major advantage of this technique is its
ability to read up to 1000 bp of DNA, making it applicable for
methylation proﬁling of highly repetitive genomic regions.91
Although this technique detects N6-methyladenine with high
sensitivity, enhancement of kinetic sensitivity is likely to be
required for 5-methylcytosine and 5-hydroxymethylcytosine.91
Metal-DNA ComplexeMediated Electrochemical
Detection
Novel sequence-speciﬁc osmium complexation was per-
formed on methylcytosine to distinguish between methyl-
cytosine and no methylcytosine by ﬂuorimetric and
electrochemical detection.92 Interstrand cross-links between
osmium and DNA facilitated the identiﬁcation of methyl-
ated cytosines and the degree of methylation.93 Researchers
have also used a combination of either V2O5 and LiBr or
NaIO4 and LiBr to detect 5-methylcytosines in the presence
of normal bases.94
Short oligonucleotides with different numbers of
5-methylcytosines were measured using an electron cyclo-
tron resonance (ECR) sputtered nanocarbon ﬁlm electrode
without the need for sodium bisulﬁte treatment or separation
processes.95 Figure 6 shows the background-subtracted
square wave voltammograms of the methylated and non-
methylated oligonucleotides. The responses matched exactly
with the base content of each oligonucleotide, and the C
methylation ratio in oligonucleotides could be approxi-
mately quantiﬁed from the heights of the oxidation currents
of both methyl cytosine and cytosine. However, it is tedious
to analyze DNA methylation in the low concentration
region using a GC electrode because of a large background
current and also using a boron-doped diamond electrode
because of low electrochemical activity.95 Consequently,
the target CpG oligonucleotide was digested with endonu-
clease P1 because direct electrochemistry of longer CpG
oligonucleotides was insufﬁcient to obtain the required
oxidation currents.96 The results were achieved with 4.4
times higher sensitivity and a wider concentration range for
5-methylcytosine detection and better resolution for 60mer
length.96 This method may be used to detect DNA meth-
ylation in real genomic samples and for longer oligonu-
cleotides, including non-CpG sequences.96
Separation processes, such as high-performance liquid
chromatography, have also been reported by several groups
for methylation analysis. High-performance liquid chroma-
tography with electrochemical detection was used for
a DNA methylation assay using a BDD electrode after
chemical hydrolysis.97
Atomic Force Spectroscopy
Our group has explored the technique of force spectroscopy to
measure the intermolecular force behavior of monoamineThe Journal of Molecular Diagnostics - jmd.amjpathol.orgoxidase B and Pseudarthria viscida (L.).98 Force spectroscopy
measures the relationship between the length of the molecule
and the tension and is used to examine the nanomechanics and
mechanochemistry of DNA, sugars, and proteins.99e102 To
evaluate DNA methylation patterns, methylated single-
stranded DNA molecules are linked to a glass substrate and
an antie5-methylcytosine antibody is attached to the tip of an
AFM (Figure 7A).99 When the tip contacts the DNA, two
complexes are formed between the two Fab arms of the anti-
body and force peaks are captured by stretching the DNA-
antibody complex that is attached to the AFM; the methyla-
tion patterns are determined by analyzing the separations
between the force peaks. However, the inability to detect the
rupture events involving two neighboring 5-methylcytosines is
a drawback of this technique. Researchers are working to
eliminate this limitation by using antibody fragments instead of
the whole antibody, because their smaller size permits binding
to neighboring bases (Figure 7, BeD).99
Summary
Many underlying molecular mechanisms of human diseases
and tissue-speciﬁc gene expression have been discovered
with DNA methylation analysis studies. However, the
acquisition of reliable data on DNA methylation status is
limited by several factors, including the high quantity and
quality of DNA samples required for testing. Moreover, it is
tedious to correlate a particular methylation pattern to
a speciﬁc cell type because of cellular heterogeneity. No
single technique is ﬂexible enough to accomplish all of the
criteria for producing exemplary results. Among a variety of
methods that have been developed to explore methylation
patterns, sodium bisulﬁteebased PCR methods and restric-
tion enzymeebased methods have been practical as
sequencing-based methods. We foresee that force spectros-
copy, in combination with the currently used methods, would
improve the accuracy of detection of methylation. Hence, the
choice of the method of investigation depends on the nature,
quantity, and quality of the biological samples, the available
equipment, and the expertise of the researcher. The ideal
selection of a methylation detection method or a combination
of methods will ensure the generation of reliable and repro-
ducible results with greater sensitivity and speciﬁcity.
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